JamesRRunoMD

Pulmonology • Madison, WI

Critical Care Medicine, Pleural Disease

Assistant Professor, Medicine, University of Wisconsin Medical School

Join to view full profile

Dr. Runo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Runo's full profile

Already have an account?

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-263-7203

Fax+1 608-263-9103

Education & Training

Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
Indiana University School of MedicineResidency, Internal Medicine, 1997 - 2000
Indiana University School of MedicineClass of 1997

Certifications & Licensure

IL State Medical License 2010 - 2026
IN State Medical License 1998 - 2025
WI State Medical License 2004 - 2025
TN State Medical License 2000 - 2005
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension Start of enrollment: 2011 Jan 01
Completed
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension Start of enrollment: 2009 Dec 01
Completed
Phase 3
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF) Start of enrollment: 2011 Apr 01
Completed
Not Applicable
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE Start of enrollment: 2017 Feb 03
Completed
Phase 2, Phase 3
Pulmonary Hypertension Association Registry Start of enrollment: 2015 Oct 01
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Diseas...
Kathryn T Del Valle, Dana Kay, Michael J Krowka, James R Runo, Corey Sadd
Transplantation Direct. 2025-03-01
Medication Non-Adherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
Eric W Robbins, Kaitlin Bradley, David B Badesch, Charles Burger, Amy M Chybowski
Annals of the American Thoracic Society. 2025-02-18
Ventricular interdependent phenotype of mixed Cpc-pulmonary hypertension and HFpEF with normal left atrium: Impact on CPET metrics and clinical outcomes.
Giovanna Zampierollo-Jaramillo, Anas Abed, Ahmed El Shaer, Mariana Garcia-Arango, Yimin Chen
Pulmonary Circulation. 2024-10-01